The bill would reduce PFAS exposure from food packaging and likely lower long-term health and cleanup costs, but it creates short-term compliance costs that may raise food prices for vulnerable consumers and may face legal/enforcement hurdles that could delay protections.
Consumers — especially children and people with chronic health conditions — will have reduced exposure to PFAS in packaged foods starting Jan 1, 2027, lowering risks of certain cancers and endocrine disruption.
Food companies will be incentivized to switch to safer packaging, which could reduce long-term cleanup and healthcare costs tied to PFAS contamination and shift industry practices away from persistent chemicals.
Low-income consumers and taxpayers may face higher food prices as manufacturers and packagers incur compliance and reformulation costs to remove PFAS by 2027.
Regulators, manufacturers, and consumers could see delayed or uneven protections because the bill's narrow statutory definitions may trigger enforcement challenges and legal disputes over whether specific chemicals or legacy contamination are covered.
Based on analysis of 2 sections of legislative text.
Bans interstate commerce of food packaging with intentionally added PFAS as defined, effective January 1, 2027.
Official title: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the introduction or delivery for introduction into interstate commerce of food packaging containing intentionally added PFAS, and for other purposes.
Introduced July 6, 2026 by Debbie Dingell · Last progress July 6, 2026
Prohibits the interstate sale or shipment of any food packaging that contains intentionally added PFAS chemicals, defining PFAS by a specific fluorination criterion. The prohibition takes effect January 1, 2027. The law adds this ban to existing food law as a new prohibited act under the Federal Food, Drug, and Cosmetic Act, making it unlawful to introduce or deliver for introduction into interstate commerce food packaging with intentionally added PFAS as defined.